Endobronchial Ultrasound (EBUS) Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Endobronchial Ultrasound (EBUS) Devices Market: by Type (Radial EBUS, Linear EBUS, Sequential Transbronchial Needle Aspiration (TBNA), CP-EBUS, Real-time Transbronchial Needle Aspiration (TBNA)), Indication (Lung Cancer, Endobronchial Lesions, Mediastinal, and Hilar lymphadenopathy, Lymphoma, Others), End-user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Endobronchial Ultrasound (EBUS) Devices Market size is expected to be USD x million in 2021, growing at a high CAGR of 4.6% from 2022 to 2028 to reach USD x million by 2028. Endobronchial Ultrasound (EBUS) Devices Market has emerged as a routinely performed procedure in diagnostic bronchoscopy. It is a minimally invasive procedure. It is a combination of bronchoscopy and ultrasound. It is used for the evaluation of tumor involvement of the tracheobronchial wall and mediastinum and plays an essential role as a guidance technique for peripheral pulmonary disease.  EBUS plays a vital role in the minimally invasive staging of nonsmall cell lung cancer. The role of EBUS is progressively expanding to include peribronchial lesions, pulmonary nodules, and other mediastinal abnormalities. Recently, EBUS has assisted in the diagnosis of many other disease entities, including malignancies and various infections like TB and sarcoidosis. It is significantly cost effectively when compared to standard techniques. In 2016, American Association created 3 new CPT codes for EBUS. Players are also focussing on various growth strategies such as new product launches and development, acquisitions, collaborations, and partnerships to enhance their market presence in the global EBUS devices market. For Instance, in May 18, 2017, Olympus launched its new ViziShot 2 single-use aspiration needles and expanded the EBUS Transbronchial Needle Aspiration device portfolio. In 2014, Cook Medical introduced EchoTip ProCore the first EBUS needle in the U.S. and Europe that can acquire histological samples. The market is growing due to an increase in demand for minimally invasive medical procedures and widespread adoption of the procedure by interventional radiologists and diagnostic departments to diagnose diseases for healthcare institutions such as medical clinics and diagnostic centers, among others. The market is also influenced by people’s growing knowledge of early diagnosis and its benefits, as well as the widespread use of biopsy to diagnose cancer and identify healthy cells or calluses from tumorous cells.

 

Endobronchial Ultrasound (EBUS) Devices Market

MARKET SUMMARY
-
4.6% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 4.6%
  • Largest Market– North America
  • Fastest Growing Market–  North America

Endobronchial Ultrasound (EBUS) Devices Market

  • The report on global Endobronchial Ultrasound (EBUS) Devices Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, indication, end user and geography.
  • Endobronchial Ultrasound (EBUS) Devices Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Cook Medical (U.S)
  • Pentax Medical (Japan)
  • Hitachi Medical Systems Europe
  • Olympus Medical Systems (Japan)
  • Boston Scientific Cooperation (U.S)
Endobronchial Ultrasound (EBUS) Devices Market Drivers And Restraints

Increase in the prevalence and incidence of cancer propels the growth of the Endobronchial Ultrasound (EBUS) Devices market globally. As per the stats of cancer research U.K in 2014, 46403 new cases of lung cancer were reported and according to American Lung Association 1.8Mn new cases were reported worldwide in 2012. Furthermore growing geriatric population, increase in healthcare expenditure, technological advancements and developments and advanced healthcare services also propels the market growth of Endobronchial Ultrasound (EBUS) Devices globally. However, lack of awareness regarding EBUS, availability in few regions may hinder the growth of Endobronchial Ultrasound (EBUS) Devices growth globally.


North-America Got Significant Share

Endobronchial Ultrasound (EBUS) Devices Market

Geographically, global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North American Endobronchial Ultrasound (EBUS) Devices market expected to register significant growth followed by Europe owing to adaptation of advanced technologies and favourable regulatory environment. Asia Pacific market is expected to grow at faster rates owing to rise in chronic diseases prevalence, increase in air pollution, developing healthcare infrastructure and low cost of manufacturing of devices in developing regions such as India and China. Latin America and The Middle East and Africa respiratory devices market is expected to grow at notable rates owing to increase in geriatric population, prevalence of chronic diseases such as lung cancer , and growing awareness among people.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Endobronchial Ultrasound (EBUS) Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The endobronchial ultrasound devices market is projected to expand at a CAGR of 4.6%  during the forecast period

 

Bio-Rad Laboratories, Inc, Biocept, Inc, Illumina, Inc, AstraZeneca plc, Epigenomics AG

North America is the fastest-growing region for the endobronchial ultrasound devices market

 


Report

Table Of Content


Report

Company Profile

  • Cook Medical (U.S)
  • Pentax Medical (Japan)
  • Hitachi Medical Systems Europe
  • Olympus Medical Systems (Japan)
  • Boston Scientific Cooperation (U.S)

Description

Endobronchial Ultrasound (EBUS) Devices Market size is expected to be USD x million in 2021, growing at a high CAGR of 4.6% from 2022 to 2028 to reach USD x million by 2028. Endobronchial Ultrasound (EBUS) Devices Market has emerged as a routinely performed procedure in diagnostic bronchoscopy. It is a minimally invasive procedure. It is a combination of bronchoscopy and ultrasound. It is used for the evaluation of tumor involvement of the tracheobronchial wall and mediastinum and plays an essential role as a guidance technique for peripheral pulmonary disease.  EBUS plays a vital role in the minimally invasive staging of nonsmall cell lung cancer. The role of EBUS is progressively expanding to include peribronchial lesions, pulmonary nodules, and other mediastinal abnormalities. Recently, EBUS has assisted in the diagnosis of many other disease entities, including malignancies and various infections like TB and sarcoidosis. It is significantly cost effectively when compared to standard techniques. In 2016, American Association created 3 new CPT codes for EBUS. Players are also focussing on various growth strategies such as new product launches and development, acquisitions, collaborations, and partnerships to enhance their market presence in the global EBUS devices market. For Instance, in May 18, 2017, Olympus launched its new ViziShot 2 single-use aspiration needles and expanded the EBUS Transbronchial Needle Aspiration device portfolio. In 2014, Cook Medical introduced EchoTip ProCore the first EBUS needle in the U.S. and Europe that can acquire histological samples. The market is growing due to an increase in demand for minimally invasive medical procedures and widespread adoption of the procedure by interventional radiologists and diagnostic departments to diagnose diseases for healthcare institutions such as medical clinics and diagnostic centers, among others. The market is also influenced by people’s growing knowledge of early diagnosis and its benefits, as well as the widespread use of biopsy to diagnose cancer and identify healthy cells or calluses from tumorous cells.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX